Pulmonary thrombosis and Adverse event
Summary:
Adverse event is found among people with Pulmonary thrombosis, especially for people who are female, 60+ old.
The study analyzes which people have Adverse event with Pulmonary thrombosis. It is created by eHealthMe based on reports of 15 people who have Pulmonary thrombosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Pulmonary thrombosis?
Pulmonary thrombosis (scarring in the lungs) is found to be associated with 716 drugs and 715 conditions by eHealthMe. Check the latest studies of Pulmonary thrombosis.
What is Adverse event?
Adverse event is found to be associated with 1,683 drugs and 1,668 conditions by eHealthMe. Check the latest studies of Adverse event.
15 people who have Pulmonary Thrombosis and Adverse Event are studied.

Gender of people who have Pulmonary Thrombosis and experienced Adverse Event *:
- female: 64.29 %
- male: 35.71 %
Age of people who have Pulmonary Thrombosis and experienced Adverse Event *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 44.44 %
- 60+: 55.56 %
Common co-existing conditions for these people *:
- Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 13.33%
- Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 13.33%
- Cardiac Disorder: 2 people, 13.33%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
- Embolism Venous (embolus may pass into the arterial system): 1 person, 6.67%
- Dizziness: 1 person, 6.67%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.67%
- Blood Pressure Abnormal: 1 person, 6.67%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
Common drugs taken by these people *:
- Xarelto: 12 people, 80.00%
- Eliquis: 2 people, 13.33%
- Coumadin: 2 people, 13.33%
- Zetia: 1 person, 6.67%
- Carvedilol: 1 person, 6.67%
- Donepezil: 1 person, 6.67%
- Diovan: 1 person, 6.67%
- Crestor: 1 person, 6.67%
- Cholestyramine: 1 person, 6.67%
- Celebrex: 1 person, 6.67%
Common symptoms for these people *:
- Headache (pain in head): 2 people, 13.33%
- Anaemia (lack of blood): 2 people, 13.33%
- Pain: 2 people, 13.33%
- Muscle Spasms (muscle contraction): 2 people, 13.33%
- Haemorrhage (bleeding): 2 people, 13.33%
- Head Injury: 1 person, 6.67%
- Aphonia (inability to produce voice): 1 person, 6.67%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
- Cholecystitis Infective (infection of gallbladder capable to infect other organs): 1 person, 6.67%
- Cyst (a closed sac): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Adverse event?
- Check whether Adverse event is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Pulmonary thrombosis (13,084 reports)
- Adverse event (100,133 reports)
All the drugs that are associated with Adverse event:
- Adverse event (1,683 drugs)
All the conditions that are associated with Adverse event:
- Adverse event (1,668 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Adverse event and Pulmonary thrombosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vaginal Odor in Duloxetine Hydrochloride, how severe and when it was recovered? - now
- Temperature Intolerance and drugs of ingredients of clonidine - 8 seconds ago
- Drug interactions of Starlix and Xarelto - 13 seconds ago
- Sluggishness and drugs of ingredients of bisoprolol fumarate - 16 seconds ago
- Could Lexapro cause Impulse-Control Disorder? - 21 seconds ago
- Enbrel and Faeces Discolored for Men aged 50-59 - 22 seconds ago
- Enbrel and Faeces Discoloured for Men aged 50-59 - 23 seconds ago
- Blood Calcium Decreased and drugs of ingredients of ropinirole hydrochloride - 26 seconds ago
- Gastroesophageal Reflux Disease and Loss Of Control Of Legs - 33 seconds ago
- Could Abraxane cause Chronic Obstructive Pulmonary Disease? - 34 seconds ago